C ombinations of surface proteins expressed by cells at different stages of blood cell development have enabled the isolation and subsequent functional characterization of phenotypically defined hemopoietic progenitor cell populations. In the adult mouse, the bone marrow (BM) 3 is the site of hemopoiesis where mature blood cell lineages are generated from self-renewing multipotent hemopoietic stem cells (HSC) (1) . These HSC express low levels of Thy-1.1 and high levels of stem cell Ag-1 (Sca-1 pos ) and lack expression of lineage-associated markers (Lin neg ) (2) . Phenotypically defined progenitor cell populations with restricted myeloid and/or lymphoid lineage potentials have recently been described (3) (4) (5) (6) . Expression of CD45R has been used by a number of investigators to isolate and characterize lymphoid progenitors (7, 8) , while stages of B lymphoid development before expression of CD45R are only beginning to be explored (4, 9, 10) .
A goal in enriching for early B lymphoid progenitors is to separate these cells from both HSC and differentiated cells of the B and other blood cell lineages. The latter can be achieved by depleting BM of cells expressing CD45R and other lineage-associated markers. Segregating early lymphoid progenitor cells from HSC has been more challenging. Previous studies have shown that although the Thy-1.1 low Sca-1 pos Lin neg (Thy-1.1 low ) cell population is markedly enriched for HSC, it is functionally heterogeneous (11, 12) . This heterogeneity, which is reflected in the ability of the cell population to mediate both short term and long term BM engraftment, can be dissected using separations based on cell cycle activity and activation state (13, 14) . Although experiments designed to segregate progenitors for lymphoid lineages have shown that subsets of Thy-1.1 low HSC engraft in the BM, the kinetics of B cell engraftment exhibit a 2-wk delay relative to whole BM transplants (15) . This suggests that a lymphoid progenitor cell population that is present in normal BM is missing from the Thy-1.1 low HSC population. The c-Kit molecule has also been used extensively as a cell surface marker in the purification of HSCs (16 -18 subset mediated full hemopoietic engraftment of lethally irradiated recipient animals with prominent erythroid, myeloid and platelet reconstitution and delayed lymphoid engraftment (19) . In contrast, the Thy-1.1 neg subset failed to provide erythroid and platelet engraftment to transplant recipients, but mediated rapid lymphoid engraftment with a minor degree of myeloid recovery. In the absence of full hemopoietic recovery, transplant recipients of Thy-1.1 neg cells survive only 25-30 days before death due to hemopoietic failure.
The current studies were initiated to resolve the lymphoid and myeloid potentials of Thy-1.1 neg cells at a clonal level. Using a number of additional phenotypic markers, we demonstrate three separate progenitor populations within the Thy-1. were bred and maintained at the Animal Resource Center facility of the University of Utah. Mice used were 4 -16 wk of age.
Cytokines and Abs
Steel factor (STL) and G-CSF were gifts from Gemini Science (San Diego, CA), a subsidiary of Kirin Brewery (Tokyo, Japan). Flt3 ligand (Flt3L) and IL-6 were kindly provided by Immunex (Seattle, WA). Recombinant human erythropoietin (Epo) was purchased from Ortho (Raritan, NJ). Recombinant murine IL-3 and IL-7 were purchased from PeproTech (Rocky Hill, NJ). The cytokines were used at the following concentrations: STL, 100 ng/ml; G-CSF, 10 ng/ml; Flt3L, 75 ng/ml; IL-6, 20 ng/ml; Epo, 5 U/ml; IL-3, 10 ng/ml; and IL-7, 10 ng/ml. mAbs against CD8 (53-6.7), Mac1 (M1/70), erythrocytes (TER119), Gr-1 (RB6-8C5), CD3 (KT3-1.1), CD5 (53-7. 3), CD2 (Rm2.2), mouse Ig (RAM-HB58), CD45R (RA3-6B2), Thy-1.1 (19XE5), c-Kit (ACK-4), early B cell (AA4.1), and IL-7R were purified from media of cultured hybridoma cell lines, while the mAb against CD19 was purchased from PharMingen (San Diego, CA). mAbs used for cell surface staining of CD45R, Thy-1.1, c-Kit, Gr-1, CD62L, AA4.1, and IL-7R were conjugated with biotin, PE, or FITC in our laboratory. Biotinylated Abs were secondarily stained with either PE-streptavidin (PE-SAv; Biomeda, Foster City, CA) or PE-Texas Red-SAv (Red613; Life Technologies, Grand Island, NY). In addition, PE-conjugated mAbs to Sca-1, Mac-1, and CD45R, biotinylated Abs to CD24 (M1/69) and CD43 (S7), and allophycocyaninconjugated c-Kit Ab were purchased from PharMingen. The IL-7R clone used in these studies was a gift from Richard R. Hardy (Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA).
Preparation of BM cells and isolation of hemopoietic stem/progenitor cell populations
The procedure for the preparation of BM cells for sorting has been previously described (20) . Briefly, BM cells were isolated from femurs and tibia of donor mice, and the RBCs were lysed in an ammonium chloride potassium solution. The cells were incubated in a lineage cocktail containing optimized concentrations of Abs to CD2, CD3, CD5, CD8, Mac-1, Gr-1, TER119, CD45R, and CD19. The CD45R Ab was not included in the lineage cocktail whenever CD45R expression was evaluated after lineage depletion. Lineage depletion was conducted by two successive incubations of the BM cells in sheep anti-rat Ig-coupled magnetic beads (Dynal, Oslo, Norway). The Lin neg cells were stained with PE-Sca-1 and sorted using the FACSVantage (Becton Dickinson, San Jose, CA) set at enrichment mode and thresholding on PE emissions above background levels. Dead cells were excluded from all analyses and sorts by gating on forward scatter and PI staining. The sorted Lin neg Sca-1 pos cells were pelleted and stained with allophycocyanin-c-Kit and FITC-Thy-1.1 and resorted into Thy-1.1 low cKit pos and Thy-1.1 neg c-Kit pos subsets. In experiments in which the Thy-1.1 neg c-Kit pos subset was further fractionated, the appropriate biotin-conjugated Ab stain was added and visualized using Red613-SAv. All cell sorting steps were performed using the FACSVantage, and an aliquot of the sorted cell population was always taken for reanalysis.
Methylcellulose assays
The sorted cell populations were cultured in methylcellulose at a plating density of ϳ100 cells/35-mm culture dish. Each milliliter of culture medium contained ␣-MEM (Life Technologies), 1.2% methylcellulose (Shinetsu, Tokyo, Japan), 30% FCS (Life Technologies), 1% deionized BSA (Sigma, St. Louis, MO), and 0.1 mM 2-ME (Mallinckrodt, Chesterfield, MO) supplemented with the indicated cytokine combinations. Culture dishes were incubated at 37°C and infused with 5% CO 2 . The number of colonies was counted using an inverted microscope after 7 days of culture to determine the cloning efficiency of each sorted cell population. Four to six plates were scored for each group, and the results were expressed as percentage of the total cells plated. In addition, individual colonies were plucked between days 6 and12 of culture and analyzed for both cell surface staining and cell morphology. Two-thirds of the cells harvested from each colony were stained with Abs to CD45R and Gr-1 and analyzed by flow cytometry, while cytospins were prepared from the remaining cells. Cytospins were stained with May-Grunwald-Giemsa for morphological analysis.
Liquid cultures
Liquid cultures of sorted cell populations were conducted using ␣-MEM (Life Technologies) containing 10% FCS, 1 mM MEM sodium pyruvate solution (Life Technologies), 10 mM HEPES (pH 7.3), 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM glutamine, and 0.1 mM 2-ME (Mallinckrodt) and supplemented with the indicated cytokine combinations. Cells were either grown in bulk in 24-well plates or seeded at limiting dilution (one cell per well) in 96-well plates with or without stromal cell feeder layers as indicated. Culture plates were incubated at 37°C and infused with 5% CO 2 . The 2018 stromal cell line (a gift from Kateri Moore) was maintained at 31-33°C. Cells were prepared the day before coculture by seeding 10,000 cells/well in 24-well plates for bulk cultures and 1,000 cells/well in 96-well plates for the limited dilution (clonal) assays. The presence of a single cell per well in 96-well plates was confirmed whenever possible after overnight culture using an inverted microscope. Positive clones (wells) were scored by day 5 and harvested for analysis between days 6 and 14. For bulk cultures, representative wells were harvested for analysis between days 5 and 14.
Intrathymic T cell development assay
Sublethally irradiated B6 (4-to 6-wk-old females) mice were anesthetized and immobilized with rubber bands. The skin over the chest was incised to reveal the sternum, which was cut. The thymus was visualized within the thoracic cavity, and 3 l of fluid containing the sorted cell population of interest was directly injected into the thymic tissue using a Hamilton syringe (Reno, NV). The chest was closed using stainless steel surgical clips. The cells to be transplanted were obtained from the B6-Thy-1.1-Ly-5.1 double-congenic strain and were sorted directly into a microfuge tube containing a known amount of Hanks' 10% FCS so that each 1 l of fluid contained a known number of cells. Graded doses of cells were injected into groups of animals (10 animals/group) in the presence of an excess of Lin neg cells obtained from a second B6 congenic strain (B6-Ly-1.1), which served as a carrier and as an internal control to indicate successful injections. Three or 4 wk later, the recipient B6 mice were sacrificed, and thymic tissue was isolated for analysis by flow cytometry to identify thymic lobes containing progeny cells derived from the injected populations. Successful intrathymic transfers were identified by the presence of Ly-1. 
RT-PCR assay
Sorted cells were lysed using 500 l of TRIzol (Life Technologies) with 20 g of glycogen (Roche, Indianapolis, IN) added as a carrier. The TRIzol protocol for RNA isolation prescribed by the manufacturer was followed using half volumes. After isopropanol precipitation, the RNA pellet was washed twice in 70% ethanol and resuspended in 8 l of diethylpyrocarbonate-treated water. The RNA samples were incubated with 1 l of amplification grade DNase I (Life Technologies) and 1 l of 10ϫ DNase I buffer at room temperature for 15 min to eliminate any contaminating DNA. The reaction was stopped with the addition of 1 l of 25 mM EDTA and heating at 72°C for 10 min. Water was added to bring the total volume of each reaction to 20 l. Five to 10 l from each total RNA sample was used for first-strand synthesis using random primers (Life Technologies) and Moloney murine leukemia virus reverse transcriptase (Life Technologies) following the protocol provided by the manufacturer.
Semiquantitative PCR was used to compare the expression of genes between sorted cell populations. All primer sequences used in this study have been previously described. To equalize for cDNA input, each sample was first amplified by PCR using GAPDH primers (21) , and the amount of input cDNA was adjusted to provide equivalent signals. Subsequent PCR amplifications used the predetermined amount of cDNA with gene-specific primers for sterile Ig heavy chain transcript o , Rag-2, E2A, Pax-5, and CD19 (7, 22, 23) . PCR cycle parameters used for GAPDH, o , and Rag-2 were described by Li et al. (22) , while those for E2A, Pax-5, and CD19 were described by Bain et al. (23) . Fifteen-microliter aliquots were withdrawn at cycles 24, 27, and 30 (GAPDH) or cycles 27, 30, and 33 ( o , Rag-2, E2A, Pax-5, and CD19) to assure that amplification was within the linear range. The PCR products were separated by 1% agarose gel electrophoresis. Quantitation was performed using the MultiAnalyst program (Bio-Rad, Hercules, CA). Individual bands were measured and normalized using the GAPDH signal for each sample. Comparison of gene expression between samples was achieved by comparing the normalized value for each sample to the value obtained for CD45R pos cells.
Results
The neg population included cells expressing both low and high levels of c-Kit. Cells lacking c-Kit expression were not further characterized in these studies. Because of concerns regarding contamination of Thy-1.1 neg cell preparations with Thy-1.1 low HSC, reanalysis of sorted populations was always performed as shown in Fig. 1 , and Thy-1.1 neg populations containing any discernable contamination with cells expressing Thy-1.1 at a level 5-to 10-fold above background levels were not used for functional studies. Although our previous transplant studies demonstrated an inhibitory influence of allophycocyanin-conjugated c-Kit Abs on in vivo engraftment of Thy-1.1 neg cells (19) , direct comparisons of cloning efficiencies and lineage potentials of Thy-1.1 neg cells isolated using biotin or allophycocyanin conjugates of anti-c-Kit Abs showed no differences in our in vitro studies.
Initial in vivo transplant studies demonstrated that the Thy-1.1 neg cell population mediates rapid BM engraftment and contributes to both lymphoid and myeloid lineages (19) . To determine whether the Thy-1.1 neg cell subset consisted of multipotent progenitors or separate progenitor cells committed to either lymphoid or myeloid lineages, we conducted clonal progenitor cell assays. The sorted cells were cultured in methylcellulose or single-cell liquid cultures supplemented with different cytokine combinations, and individual colonies were analyzed after 6 -12 days in culture by both flow cytometry and cell morphology. These analyses showed that the Thy-1.1 neg cell subset contained three types of progenitors (Table I) . Stimulation with a mixture of seven cytokines, as detailed in Table I , allowed differentiation of multiple hemopoietic lineages. Under these culture conditions, we observed colonies consisting solely of myeloid lineage cells (macrophages, primitive granulocytes, and erythroid cells), colonies consisting solely of lymphoid lineage cells (CD45R pos Gr-1 neg ), and mixed colonies containing both lineages. Lymphoid lineage colonies represented 33% of the total Thy-1.1 neg colonies analyzed, while those consisting of myeloid lineage cells represented 54% (Table  I) . Mixed lineage colonies, containing CD45R pos cells as well as myeloid cells, were observed at a frequency of 13%. Similar results were obtained in liquid cultures initiated from single cells, suggesting that the mixed lineage colonies were not the result of sampling error in the methylcellulose assay. When Thy-1.1 low HSC were cultured under the same conditions, pure lymphoid colonies were not observed, and very few mixed lineage colonies containing CD45R pos cells were scored (4%, or 2 colonies of 45 examined; Table I ). Stimulation of Thy-1.1 low HSC with lymphoid-specific cytokines (STL, IL-7, and Flt3L) resulted in a marked decrease in cloning efficiency (88 vs 581 colonies/1000 cells plated).
IL-3 has been reported to inhibit early B lymphoid differentiation (24, 25) . Consistent with this observation, we observed that omission of IL-3 from the cytokine cocktail resulted in a 40 -50% decrease in the cloning efficiency of Thy-1.1 neg cells. Analysis of the colonies that grew in the absence of IL-3 demonstrated a decrease in the frequencies of pure myeloid and mixed colonies and a concomitant increase in the proportion, but not the absolute number, of pure lymphoid colonies. Comparison between S7F6EG stimulation with or without IL-3 showed that 33% of 148 Ϯ 44 colonies were lymphoid in the presence of IL-3 (48.8 Ϯ 14 colonies/1000), whereas 60% of 81 Ϯ 29 colonies were lymphoid in the absence of IL-3 (48.6 Ϯ 17 colonies/1000; Table I ). Thy-1.1 neg cells grown in methylcellulose cultures supplemented with cytokines permissive only for lymphoid differentiation (S7F) exhibited a 6-fold decrease in cloning efficiency compared with the more complex cytokine combination, and all colonies evaluated from Fig. 2D ), which was similar to the distribution of the Sca-2 Ag (data not shown). CD3 served as a negative control and was expressed by Ͻ1% of Thy-1.1 neg cells (Fig. 2E ). Since expression of AA4.1 and IL-7R have previously been associated with early lymphoid progenitors (4, 6, 7, 26), we focused on the c-Kit low subset of cells for additional phenotypic and functional analysis.
A hierarchy of progenitors in the B lymphocyte developmental pathway has been described by Hardy and colleagues, who used cell surface Ag expression to define specific developmental stages (4, 7, 27) . To better place the Thy-1.1 neg c-Kit low progenitor population in the context of the previous studies, we evaluated CD45R, CD24, and CD43 expression by these cells. Unlike the primitive pro-B cell described by Hardy's stage A, Thy-1.1 neg cKit low cells largely lack expression of CD45R and express high levels of CD24 (Fig. 2, F and G) . In common with Hardy's stage A of development, Thy-1.1 neg c-Kit low cells express lower levels of CD43 relative to Thy-1.1 low stem cells (Fig. 2H ). Hardy and colleagues used expression of AA4.1 along with CD4, CD24, and CD43 to identify a CD45R neg stage of B cell development preceding the A stage (7), but the isolation protocol used in those studies failed to segregate these cells away from erythroid lineage progenitors (4) . Furthermore, functional assessment of B lineage precursors in adult mouse bone marrow established that most early B lineage progenitors express CD24, as detected using either the M1/69 or 30-F1 Ab (9) . To summarize, Thy-1.1 neg c-Kit low cells overlap with Lin neg TdT ϩ cells as defined by Tudor et al. (9) , but differ from fraction A 0 as defined by Hardy and colleagues (7) in that most Thy-1.1 neg c-Kit low cells lack CD4 and express high levels of CD24 (Fig. 2, D and G) . (Fig. 2A) . Methylcellulose and liquid cultures were initiated with each c-Kit/AA4.1 subset to ascertain their cloning efficiencies and myeloid and/or lymphoid differentiation potential. These cultures were supplemented with cytokine combinations selected to either support proliferation and differentiation toward the lymphoid lineage (STLϩ IL-7 ϩ Flt3L, S7F), the myeloid lineage (IL-3 ϩ IL-6 ϩ Epo ϩ G-CSF, 36EG), or both lymphoid and myeloid lineages (STL ϩ IL-7 ϩ Flt3L ϩ IL-3 ϩ IL-6 ϩ Epo ϩ G-CSF, S7F36EG). FIGURE 2. BM cells from young (5-to 6-wk-old) adult mice were lineage depleted using an Ab cocktail as described in Materials and Methods, substituting a CD19 monoclonal in place of CD45R. This population was subsequently stained with mAbs to Sca-1, c-Kit, and Thy-1.1 and sorted for Thy-1.1 neg and Thy-1.1 low cells as described in Fig. 1 
neg cells cloned at a frequency of 20% in S7F36EG and gave rise to myeloid or mixed colonies, but not pure lymphoid colonies (Table II) . Cloning efficiency dropped to 5% when the cells were stimulated under lymphoid conditions. In contrast, the two cKit low populations resolved by AA4.1 staining showed equivalent colony growth in either lymphoid-specific or complex cytokine conditions, suggesting that the majority of clonogenic c-Kit low cells are lymphoid committed (Table II) Fig. 3A . The c-Kit low AA4.1 neg subset did not produce visible colonies until day 7 in culture. At this time, an equivalent number of pure lymphoid and mixed colonies was observed. On subsequent days, only pure lymphoid colonies were detected. A similar pattern was observed when c-Kit low AA4.1 pos cells were cultured, except that colonies appeared 1 day earlier, and pure lymphoid colonies always outnumbered mixed colonies. Thus, the mixed lineage potential of the Thy-1.1 neg c-Kit low subsets of cells was limited, and detection of the myeloid progeny was transient. Fig. 1 . This population was further fractionated into the indicated populations as shown in Fig. 2A and 3A .
b Cultures were initiated in methylcellulose medium containing the indicated cytokines as described in Materials and Methods. Cytokines are abbreviated as follows: S, STL; 7, IL-7; F, Flt3L; 3, IL-3; 6, IL-6; E, Epo; G, G-CSF.
c Colonies numbers were evaluated on day 8 of culture. d Lineage content was evaluated as in Table I on days 6 -12 of culture. The kinetics of colony evolution shown in Fig. 3A Fig. 2F , the majority of cells defined by the phenotype Thy-1.1 neg c-Kit low AA4.1 pos do not express CD45R, and our clonal assays indicate that this cell subset consists almost exclusively of lymphoid-committed progenitors (Table II and Fig.  3A) . However, the efficiency of magnetic bead depletion may not be absolute, particularly for cells expressing low levels of the target Ag. In addition, the cloning efficiency of Thy- pos subsets of Thy-1.1 neg c-Kit low cells by automatic cell deposition FACS sorting were seeded into microtiter wells containing cytokines alone (S7F36EG or S7F) or in the presence of S7F plus three different stromal lines reported to support B lymphoid development (Fig. 4A) . Any of three different bone marrow stromal cell lines (S17 (29), AC6 -2.1 (30) , and 2018 (31)) in the presence of exogenous S7F enhanced the cloning efficiency of AA4.1 pos cells by about 2-fold, while the AA4.1 neg subset cultured with S7F and the 2018 stromal line exhibited only a slight enhancement in cloning efficiency compared with S7F stimulation in the absence of stromal cells (Fig. 4A) . Individual clones were harvested and evaluated for expression of surface Ags by flow cytometry. On days 11 and 12 of culture, single cells cocultured with 2018 in the presence of S7F had expanded to colonies ranging from 10 4 to 3 ϫ 10 4 cells and expressed CD45R, CD24, and BP1 uniformly and CD43 at variable levels. Surface IgM (sIgM) expression was observed on very few cells (data not shown). Bulk cultures established from 5 ϫ 10 2 AA4.1 neg or AA4.1 pos cells in S7F with or without 2018 cells expanded to 350-to 900-fold (60 -70% viable) in 7 days and 1200-fold (30% viable) in 14 days, demonstrating the extensive proliferative potential of these cells. After 14 days in culture, sIgM expression could be detected on a small subset of cells growing either in cytokines alone or on 2018 cells in the presence of S7F (Fig. 4B) . However, only about 10% of the cells in the sIgM neg population expressed cytoplasmic IgM on day 11, supporting the interpretation that most of the expanding cells in the cultures represent pro-B cells. This result is also consistent with recent studies suggesting that high levels of IL-7 lead to expansion of cIgM neg pro-B cells, and that selective regulation of IL-7 dose-response thresholds leads to preferential outgrowth of pre-B cells expressing productively rearranged IgM in association with the surrogate light chains and signaling components of the pre-B cell receptor (32) . These results demonstrate high cloning pos cell subsets was 1 in 160 and Ͻ1 in 620, respectively (Fig. 5) . This result supports the interpretation that expression of AA4.1 coincides with B lineage commitment, since a frequency of 1 in 620 could be explained by contamination with populations of cells outside our sorting gates. The low frequency of T cell progenitors in the c-Kit low AA4.1 neg population suggests that common lymphoid progenitors can account for only a subset of these cells.
Expression of B lineage-associated genes in the Thy-1.1 neg c-Kit low lymphoid-committed progenitor subsets
The results of the in vitro clonal assays and the intrathymic injections suggest that the majority of c-Kit low AA4.1 pos cells are committed to the B lymphoid lineage at a developmental stage coincident with up-regulation of CD45R expression. Commitment to the B lymphoid lineage occurs before Ig heavy chain rearrangement (4) and is associated with transcriptional activation of this locus, resulting in the expression of germline transcripts ( o ) (7) as well as the expression of a number of genes that are required for (22) . Transcription of o has been shown to reflect the accessibility and competence of the region for Ig gene rearrangements (7, 33) . In addition, recent studies have established the importance of a number of transcription factors in lymphoid development (34) . Three of these proteins, products of the Pax5, E2A, and EBF genes, are essential in both B cell lineage commitment and B cell development (23, (35) (36) (37) . To better establish the stage of development represented by the two AA4.1 subsets of Thy-1.1 neg c-Kit low cells, we performed gene expression analysis by semiquantitative RT-PCR. We determined the expression of o , Rag-2, E2A, Pax5, and CD19 in the various Thy-1.1 neg cell populations compared with CD45R pos BM cells (Fig. 6 ). Rag-2 expression was detected at equivalent levels in all samples. In contrast, o transcripts were highly expressed by Thy-1.1 neg c-Kit low cells and by the two AA4.1 subsets relative to the total population of CD45R ϩ cells. Since the target sequence for the 5Ј oligonucleotide used to prime this amplification is deleted upon IgH D-J rearrangement (7, 33) , this result demonstrates that both AA4.1 subsets include cells with at least one transcriptionally active allele of the IgH gene in germline configuration. 
Discussion
Transplant studies have previously shown that the Thy-1.1 neg population is enriched for committed lymphoid progenitors that can readily engraft in the recipient BM (19) . Here we demonstrate that the Thy-1.1 neg cell population contains three progenitor populations, including separate committed progenitors for both lymphoid neg cells described by Tudor and colleagues suggests that the two isolation protocols define a similar population of cells. However, the selection protocol described in the present studies may provide a better separation of lymphoid and myeloid progenitors, since up to 30% of clones grown on S17 stromal cells by Tudor and colleagues were of myeloid lineage. It is likely that the selection against Thy-1.1 expression in the present studies accounts for the increased resolution of B lymphoid progenitors from multipotent stem cells and myeloid progenitors.
Recently, a common lymphoid progenitor with the phenotype Thy-1.1 neg Sca-1 low c-Kit low Lin neg IL7R pos has been reported (6) . This cell population possesses rapid and prominent lymphoid-restricted potential with limited or no self-renewal activity. Since most of the cells in the Thy-1.1 neg c-Kit low subset express IL-7R (Fig. 2B ), this population of cells overlaps almost entirely with the common lymphoid progenitor of Kondo and colleagues. In contrast to the findings of that group, we demonstrate that T lineage potential is low among Thy-1.1 neg c-Kit low AA4.1 neg cells and is absent from the Thy-1.1 neg c-Kit low AA4.1 pos subset (Fig. 5 ). One obvious difference between the two sets of experiments is the short-term culture in S7F used by Kondo and colleagues to prove that the clonal progeny of single cells could differentiate into both the T and B lineages. A similar observation was reported by Jacobsen and colleagues, who showed that c-Kit high Sca-1 pos Lin neg HSC could be cultured for up to 2 weeks in IL-7 and Flt3L and that the cultures, when transplanted i.v., reconstituted T and B, but not myeloid, lineages (41) . Older studies by Phillips and colleagues reported similar findings using long term bone marrow cultures transplanted into immunodeficient recipient mice (42) . These results are also consistent with studies using animals mutated at the Pax5 locus, since pro-B cells from these animals could be cultured long term in IL-7 while retaining T lineage potential (43) . Taken with the results shown in Fig. 5 , these observations indicate that common lymphoid progenitors will default to the B lineage unless specific stimulation with cytokines precedes thymic engraftment. This is consistent with an inductive mechanism for the T lineage, rather than a permissive or stochastic developmental pathway. Kondo and colleagues proposed two pathways of development for conventional B lymphocytes. One of these branches early from the HSCs, has the potential to develop in the T or B lineage but has no myeloid potential, and expresses IL-7R. The other pathway branches later, has potential to develop as B lineage and a limited array of myeloid cells, and lacks the IL-7R. Although the Thy-1.1 neg cell populations reported here as well as that reported by Kondo and colleagues are capable of rapid BM reconstitution, giving rise to predominantly lymphoid lineage cells, the Thy-1.1 neg c-Kit high cell subset as isolated in these studies retains some myeloid differentiation potential. Thus, we suggest that the mixed lineage progenitor described within the Thy-1.1 neg c-Kit high cell subset (Table II) (Fig. 7) .
Our analysis of T cell potential in the Thy-1.1 neg cell population shows that these cells can differentiate in the thymus after intrathymic injection (Fig. 5) . Most of the T cell potential is contained in the Thy-1.1 neg c-Kit low AA4.1 neg cell subset. However, the frequency of cells in this subset that engraft intrathymically is 32-fold lower than the frequency of T cell progenitors found when Thy-1.1 low HSC are injected (2) . This suggests that Thy-1.1 neg c-Kit low cells may predominantly be committed to the B cell lineage and that T cell progenitors may largely lie outside this subset of cells. Alternatively, the low frequency of T cell clones observed relative to Thy-1.1 low HSC may represent a difference in proliferative expansion before the onset of TCR rearrangements. T cell clones derived from progenitors at later stages of development would appear earlier and would be smaller and may not be observed if they fail positive or negative selection before becoming large enough to be detected in this assay. Most studies indicate that the rate of emigration of progenitor cells into the thymus is quite low (45) . Several lines of evidence suggest that it is a committed progenitor rather than a pluripotent HSC that seeds the thymus to initiate T cell development (46 -48) . We therefore expect to find a BM progenitor with sufficient proliferative activity to maintain production of T lineage cells in the thymus in the absence of large scale replenishment from marrow-derived sources. The sizes of thymic clones should reflect the amount of proliferation they can undergo before rearrangement of TCR genes and subsequent selection. Additional experiments to localize T cell progenitors immediately outside the HSC compartment will be addressed in the immediate future.
A number of investigators have characterized early B cell development by isolating and characterizing early progenitors based on CD45R expression. The earliest of these progenitors is thought to lack CD24 expression (7, 49, 50) and to up-regulate this marker as differentiation proceeds. The Thy-1.1 neg c-Kit low cell population isolated in these studies has strong hallmarks of being a transitional cell between the HSC and the progenitors for lymphoid lineages. Like the HSC, the Thy-1.1 neg c-Kit low progenitor is CD45R neg and expresses CD24, with the CD24 expression being slightly higher compared with HSC (Fig. 2G) . In addition, Thy-1.1 neg c-Kit low cells will proliferate in response to the lymphoidselective cytokine combination of S7F, exhibiting a cloning efficiency of 4 -8% under these conditions (Table II and pos IgM neg B cell stage, but were inefficient at supporting further differentiation (Fig. 4B) . Modulation of IL-7 concentrations in these cultures may be necessary to select the rare cells that successfully complete Ig gene rearrangement (32, 51) .
Recent studies have established the importance of a number of transcription factors in lymphoid development (52) . Three of these proteins, products of the Pax5, E2A, and EBF genes, are specifically associated with commitment to the B cell lineage (53) (54) (55) . Targeted mutation of E2A or EBF results in a block in B cell development at a stage before Ig gene rearrangements, while Pax5-deficient mice initiate D-J H rearrangement but arrest before V-DJ H rearrangements (37) . Interestingly, Pax-5 deficiency leads to the growth of pro-B cells at a stage of development that allows lineage reprogramming even after extensive culture in the presence of IL-7 (36). Thus, cultured Pax5-deficient cells that are phenotypically identical with native pro-B cells and have rearranged their Ig D-J H gene segments can subsequently be induced to differentiate as T lineage lymphocytes or even as macrophages, neutrophils, osteoclasts, dendritic cells, and NK cells (43) . This lineage reprogramming requires withdrawal of IL-7 and substitution of other lineage-inducing cytokines or microenvironments, suggestive of a deterministic regulation of differentiation at this stage of development. Our results suggest that Thy-1.1 neg c-Kit low AA4.1 neg cells represent a normal counterpart to the pseudo-pro-B cell population found in Pax5-deficient animals, and that the developmental stage at which Pax5 expression is normally up-regulated during B cell development is associated with up-regulation of AA4.1 (Fig. 6) . Enrichment of lymphoid progenitors within the Thy-1.1 neg cell population using c-Kit and AA4.1 as additional phenotypic markers is further supported by the marked increase in one of the earliest markers of B lineage commitment, o , that was observed in the lymphoid progenitor subsets compared with either the whole Thy-1.1 neg cell population or the more mature CD45R pos cells (Fig. 6) . Furthermore, the onset of Pax-5 and CD19 transcription at the AA4.1 pos stage of development corresponds to very recent activation of these genes, since the cell population does not yet express surface CD19 protein (data not shown).
The role of cytokines in supporting cell survival and promoting cell proliferation of HSCs has been the focus of several studies over the past few years (56) . In addition, there is considerable debate about whether cytokines can directly influence lineage commitment decisions of progenitor cells (57, 58) . Our data suggest that specific cytokine combinations can predictably influence the lineage outcomes of sorted Thy-1.1 neg cells. The absence of IL-3 in the cytokine combination led to a marked decrease in myeloid lineage colonies, while the combination of S7F specifically supported lymphoid lineage colonies (Table I) . In both cases, however, there was a decrease in cloning efficiency and no marked increase in the number of lymphoid colonies analyzed compared with the complex cytokine combination (S7F36EG). These observations led to the identification of separate committed progenitor cells for lymphoid and myeloid lineages contained within the Thy-1.1 neg cell population (Table II) . The results also imply that the combination of S7F selectively supports the proliferation and differentiation toward the lymphoid lineage of lymphoid-committed progenitor cells, but is not sufficient to influence lineage commitment decisions of mixed lineage progenitor cells. Similar results have been reported for the role of IL-7 in lineage commitment decisions of bipotent lymphoid-myeloid progenitor cells from mouse fetal liver (59) . The failure of apoptosis-inhibiting molecules to support continuing differentiation of B lineage cells strongly supports a selective role for extrinsic signals in lymphoid development (60) .
Finally, it should be noted that erythroid and megakaryocyte lineage cells were rarely observed in the methylcellulose cultures of Thy-1.1 neg cells and failed to recover in transplant studies. This observation that the Thy-1.1 neg cell subset gives rise to lymphocytes, macrophages, and granulocytes, but not erythrocytes and megakaryocytes, provides evidence for the early separation of the myeloid-lymphoid progenitors from the erythroid-megakaryocyte progenitors. Several other laboratories have reported similar findings recently (3, (61) (62) (63) . This is in contrast to the conventional view of the hierarchy of hemopoietic differentiation, where the lymphoid progenitors are usually depicted as separate from progenitors of the myeloid, megakaryocyte, and erythroid lineages early in the differentiation process. Cell isolation studies such as those reported here will be instrumental in defining the lineage relationships at early stages of hemopoietic development that until this point have remained elusive.
